NeuroEPO in patients with Mild-Moderate Alzheimer's disease |
01/02/2017 |
CIM |
AVATAR-2020 |
01/03/2021 |
CIGB |
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
01/07/2021 |
CIGB |
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II |
01/08/2018 |
CATALYSIS |
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. |
01/10/2020 |
CIM |
Effectiveness of a case management model for the comprehensive provision of health services to pluripathological patients |
01/11/2018 |
FUCS |
Policosanol-Atorvastatina for Ictus |
02/09/2013 |
CPN |
D002/Lyprinol for osteoarthritis |
02/09/2013 |
CPN |
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |
02/11/2014 |
CIMAB |
Moringa in Diabetes |
02/11/2021 |
CIPPPB |
Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months. |
02/12/2016 |
CPN |
Phase I/II trial with the mutein no alfa of IL-2 |
03/02/2017 |
CIM |
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. |
03/03/2023 |
CATALYSIS |
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS) |
03/03/2023 |
CIM |
HeberNasvac® Phase IV in Chronic Hepatitis B |
03/08/2018 |
CIGB |
Biomodulina T in pediatric septic shock. Exploratory study |
03/08/2020 |
BIOCEN |
Study on pneunococcal vaccination in the pediatric population from 1 year to 5 years |
03/08/2023 |
FINLAY |
MEÑIQUE Study |
03/09/2021 |
CIGB |
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
03/11/2017 |
CIM |
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana |
04/10/2023 |
FINLAY |